Skip to content

Effectiveness of Artificial Intelligent Based mHealth System to Reduce ACS Patients Bleeding Events After PCI

Effectiveness of Artificial Intelligent Based mHealth System(Chronic Disease Management System) to Reduce ACS Patients Bleeding Events After PCI: Parallel Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03738930
Enrollment
420
Registered
2018-11-13
Start date
2018-11-10
Completion date
2020-01-01
Last updated
2018-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Bleeding, Percutaneous Coronary Intervention

Keywords

Acute Coronary Syndrome, Percutaneous coronary intervention, Bleeding

Brief summary

The present study was designed to observe the effectiveness of artificial intelligent based mHealth system(Chronic disease management system) to reduce bleeding events in ACS patients undergoing PCI.

Interventions

BEHAVIORALAI based mHealth system

AI based mHealth system is used to deliver self-management contral message and health education message to make patients take notice of bleeding events after PCI.

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

age≥18 years, male or female; confirmed acute coronary syndrome patients; undergo percutaneous coronary intervention (PCI) treatment; good command of smart phones agree to participate in this clinical study and sign a written consent form.

Exclusion criteria

ACS admission deemed secondary to other cause such as traffic accidents, trauma, severe upper gastrointestinal bleeding, surgery, or procedure; patients who are not intend to attend 1 year of follow-up study or investigators find that patients are not able to comply with the study's requirements; pregnant women or lactating women; investigators consider patients who were not suitable for participation with other reasons

Design outcomes

Primary

MeasureTime frameDescription
the incidence of major bleeding during each visit between normal group and smartphone based group3 monthsBleeding definition:According to the bleeding Academic Research Congress (BARC) standard

Countries

China

Contacts

Primary ContactDandan Li, Master
cardio_lidandan@163.com+86 15711017209
Backup ContactYundai Chen, Master

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026